Episurf Medical is preparing to launch patient-specific Episealer® implants to treat osteochondral lesions of the talus in the ankle. The company seeks to perform first procedures in 2Q18.
This represents a new direction for the technology which Episurf has developed to treat damaged knee cartilage, with a patient-specific design based on medical imaging and 3D modeling. (Three Episealer knee devices are approved and commercialized in Europe, presently.)
In 2016, a surgeon implanted one patient in Germany with a custom-made Episurf device to treat an ankle joint lesion. The device was built to the surgeon’s specifications in a complex case for which a patient-specific implant was reported to be the only option. The procedure was deemed successful and the patient reported excellent results at 12-month follow-up.
Present approaches to treat osteochondral talus defects include arthroscopic debridement and bone marrow stimulation, autograft transfer, autogenous cancellous bone graft, ACI, metal resurfacing, etc.
Episurf Medical is preparing to launch patient-specific Episealer® implants to treat osteochondral lesions of the talus in the ankle. The company seeks to perform first procedures in 2Q18.
This represents a new direction for the technology which Episurf has developed to treat damaged knee cartilage, with a patient-specific design based on...
Episurf Medical is preparing to launch patient-specific Episealer® implants to treat osteochondral lesions of the talus in the ankle. The company seeks to perform first procedures in 2Q18.
This represents a new direction for the technology which Episurf has developed to treat damaged knee cartilage, with a patient-specific design based on medical imaging and 3D modeling. (Three Episealer knee devices are approved and commercialized in Europe, presently.)
In 2016, a surgeon implanted one patient in Germany with a custom-made Episurf device to treat an ankle joint lesion. The device was built to the surgeon’s specifications in a complex case for which a patient-specific implant was reported to be the only option. The procedure was deemed successful and the patient reported excellent results at 12-month follow-up.
Present approaches to treat osteochondral talus defects include arthroscopic debridement and bone marrow stimulation, autograft transfer, autogenous cancellous bone graft, ACI, metal resurfacing, etc.
Copy to clipboard 
